Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Motor Protein
100%
Imatinib Resistance
100%
CML Blast Crisis
100%
Mitotic Motor
100%
Imatinib
71%
Abl Tyrosine Kinase
42%
Cell Death
28%
BCR-ABL
28%
Philadelphia Chromosome
28%
Antisense Oligonucleotides
28%
Imatinib-resistant
28%
Microtubules
14%
Cellular Response
14%
Median Survival
14%
Cell Cycle Progression
14%
SCID Mice
14%
Oncogene
14%
Microarray Analysis
14%
Xenograft
14%
Therapeutic Target
14%
Putative Drug Targets
14%
Small Molecules
14%
Targeted Agents
14%
Resistant Cells
14%
HL-60 Cells
14%
Patient Samples
14%
T315I mutation
14%
STI571
14%
Cell Cycle Block
14%
Oligonucleotide Therapeutics
14%
S-allyl Cysteine
14%
Eg5 Inhibitor
14%
G2/M Cell Cycle
14%
Biochemistry, Genetics and Molecular Biology
Motor Protein
100%
Molecular Motor
100%
Imatinib
100%
Receptor Tyrosine Kinase
33%
Tyrosine Kinase
33%
Cell Death
22%
Oligonucleotide
22%
Antisense
22%
Philadelphia Chromosome
22%
Small Molecule
11%
Cell Cycle
11%
Cell Cycle Progression
11%
SCID Mouse
11%
Oncogene
11%
Cell pH
11%
Cysteine
11%
Pharmacology, Toxicology and Pharmaceutical Science
Imatinib
100%
Blast Cell Crisis
100%
Molecular Motor
100%
Abelson Kinase
33%
Antisense Oligonucleotide
22%
Philadelphia 1 Chromosome
22%
Cysteine
11%
SCID Mouse
11%
Neuroscience
Molecular Motor
100%
Imatinib
100%
Abelson Kinase
33%
Cell Death
22%
Antisense Oligonucleotide
22%
Philadelphia 1 Chromosome
22%
Microtubule
11%
Cell Line
11%
Cell Cycle
11%
Cell Cycle Progression
11%
Cysteine
11%
Oncogene
11%